The global anti-infectives market size reached US$ 128.45 Billion in 2021, market to reach a value of US$ 152.4 Billion by 2027, CAGR of 3.20% during 2022-2027
SHERIDAN, WYOMING, USA, November 16, 2022 /EINPresswire.com/ — The latest research study “Anti-infectives Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global anti-infectives market size reached US$ 128.45 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 152.4 Billion by 2027 exhibiting a growth rate (CAGR) of 3.20% during 2022-2027.
What is Anti-infectives ?
Anti-infectives refer to medicines that act against infections, either by inhibiting their spread or by killing the infectious agent outright. These medicines include antibiotics, antivirals, antifungals, antimalarials, anthelmintics, antiprotozoals, etc. Anti-infectives are usually administered through oral, parenteral, and topical routes.
They are extensively utilized in the treatment of minor infectious diseases, such as pneumonia and tuberculosis. Anti-infectives are also used during routine procedures and surgeries, including cesarian section and joint replacement, which are related to a high risk of severe infection.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request a free sample brochure: https://www.imarcgroup.com/anti-infectives-market/requestsample
Anti-infectives Market Trends and Drivers:
The rising product utilization in the treatment of infections, such as those caused by viruses, bacteria, parasites, fungi, etc., is among the key factors augmenting the anti-infectives market. Furthermore, the development of novel drugs that are formulated using several strategies, including natural products, quorum sensing inhibitors, gallium-based drugs, biofilm disruptors, cyclodextrin inhibitors, light-based antimicrobials, etc., is also bolstering the global market.
Moreover, the growing innovations in drug discovery procedures, such as stem cells and organ-on-chip (OOC) technologies, to enhance drug trial processes are further catalyzing the market growth. Besides this, the increasing product adoption, owing to the sudden outbreak of the COVID-19 pandemic, which has led to the increasing incidences of infections, such as aspergillosis, invasive candidiasis, and mucormycosis, is also driving the global market.
Apart from this, the expanding number of new anti-infective drugs being approved by the regulatory bodies and the improving healthcare infrastructures across countries are expected to positively influence the anti-infectives market in the coming years.
Click here to view detailed information with table of content: https://www.imarcgroup.com/anti-infectives-market
The report has been segmented the market into following categories:
Breakup by Type:
Breakup by Route of Administration:
• Intravenous (IV)
Breakup by Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Speciality Pharmacies
• Online Stores
• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
List of Major Key Players:
The major players in the market are
• Abbott Laboratories
• Cipla Health Ltd. (Cipla Limited)
• F. Hoffmann-La Roche AG
• GlaxoSmithKline plc
• Glenmark Pharmaceuticals Limited
• Johnson & Johnson
• Lupin Limited
• Sandoz AG (Novartis AG)
• Sun Pharmaceutical Industries Limited.
Key highlights of the report:
• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Browse Other Reports by IMARC Group:
Medical Gases Market Size 2022-2027: https://www.imarcgroup.com/medical-gases-market
Anti-Snoring Treatment Market Forecast: https://www.imarcgroup.com/anti-snoring-treatment-market
Biomaterials Market Growth: https://www.imarcgroup.com/biomaterials-market
Cancer Vaccines Market Size: https://www.imarcgroup.com/cancer-vaccines-market
Phototherapy Equipment Market Share: https://www.imarcgroup.com/phototherapy-equipment-market
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
IMARC Services Private Limited
email us here